Assembly of human immunodeficiency virus (HIV) antigens on bacteriophage T4: a novel in vitro approach to construct multicomponent HIV vaccines. - Wikidata - awgldk - TriplyDB

Assembly of human immunodeficiency virus (HIV) antigens on bacteriophage T4: a novel in vitro approach to construct multicomponent HIV vaccines.

Assembly of human immunodeficiency virus (HIV) antigens on bacteriophage T4: a novel in vitro approach to construct multicomponent HIV vaccines.

http://www.wikidata.org/entity/Q35023762

about

Structure and assembly of bacteriophage T4 head Genetically Engineered Phages: a Review of Advances over the Last Decade Structure, assembly, and DNA packaging of the bacteriophage T4 head Structure and function of bacteriophage T4 Fc receptor-mediated, antibody-dependent enhancement of bacteriophage lambda-mediated gene transfer in mammalian cells Structure of the Three N-Terminal Immunoglobulin Domains of the Highly Immunogenic Outer Capsid Protein from a T4-Like Bacteriophage Phage Therapy: Combating Infections with Potential for Evolving from Merely a Treatment for Complications to Targeting Diseases Mutated and bacteriophage T4 nanoparticle arrayed F1-V immunogens from Yersinia pestis as next generation plague vaccines Bacteriophages and Their Immunological Applications against Infectious Threats.Multicomponent anthrax toxin display and delivery using bacteriophage T4.T4 bacteriophage as a phage display platform.Purification of phage display-modified bacteriophage T4 by affinity chromatography Functional analysis of the highly antigenic outer capsid protein, Hoc, a virus decoration protein from T4-like bacteriophages.Phages and HIV-1: from display to interplay.Immunization with M2e-displaying T7 bacteriophage nanoparticles protects against influenza A virus challenge.Designing a soluble near full-length HIV-1 gp41 trimer.Immunogenicity studies of proteins forming the T4 phage head surface.Dense display of HIV-1 envelope spikes on the lambda phage scaffold does not result in the generation of improved antibody responses to HIV-1 Env.T4 phage and its head surface proteins do not stimulate inflammatory mediator production Anthrax vaccine antigen-adjuvant formulations completely protect New Zealand white rabbits against challenge with Bacillus anthracis Ames strain spores.A New Approach to Produce HIV-1 Envelope Trimers: BOTH CLEAVAGE AND PROPER GLYCOSYLATION ARE ESSENTIAL TO GENERATE AUTHENTIC TRIMERS Oral Application of T4 Phage Induces Weak Antibody Production in the Gut and in the Blood.Assembly of the small outer capsid protein, Soc, on bacteriophage T4: a novel system for high density display of multiple large anthrax toxins and foreign proteins on phage capsid.In vitro and in vivo delivery of genes and proteins using the bacteriophage T4 DNA packaging machine.Generation of affinity-tagged fluoromycobacteriophages by mixed assembly of phage capsids.Human immunodeficiency virus type 1 Gag p24 alters the composition of immunoproteasomes and affects antigen presentation.Role of lipid structure in the humoral immune response in mice to covalent lipid-peptides from the membrane proximal region of HIV-1 gp41.Highly Effective Soluble and Bacteriophage T4 Nanoparticle Plague Vaccines Against Yersinia pestis.Molecular imaging of T4 phage in mammalian tissues and cells.Molecular and chemical engineering of bacteriophages for potential medical applications.Genetically modified bacteriophages in applied microbiology.Application of phage peptide display technology for the study of food allergen epitopes.Biomedical and Catalytic Opportunities of Virus-Like Particles in Nanotechnology.Bacteriophages displaying anticancer peptides in combined antibacterial and anticancer treatment.Cryo-EM structure of the bacteriophage T4 isometric head at 3.3-Å resolution and its relevance to the assembly of icosahedral viruses.Bacteriophage T4 as a Nanoparticle Platform to Display and Deliver Pathogen Antigens: Construction of an Effective Anthrax Vaccine.Orientational distributions of contact clusters in proteins closely resemble those of an icosahedron Liposomes containing glucosyl ceramide specifically bind T4 bacteriophage: a self-assembling nanocarrier formulation.Novel Therapeutic Approach for Inhibition of HIV-1 Using Cell-Penetrating Peptide and Bacterial Toxins.

P2860

Q21245107-21360663-D9D9-4295-A22C-A6BEB93DEEE7 Q26744156-073762F7-4A7F-4CF5-8B0A-3474BF4D5F70 Q26822645-62A56DC3-1BD7-4766-B887-A91DFBCA868A Q27022379-8BBBF7D1-21B3-4611-B53F-D6C973306D97 Q27486208-A045BF9C-03CA-4AA6-8F60-984D96738341 Q27668127-19272749-78E4-44DB-A640-AD75FDB85E67 Q28069939-FF6D35DE-B668-4FE8-B2E7-90CDF786A5F7 Q28678943-89AE22E8-B373-42D3-A4BB-405F5581D099 Q30234522-21C882CF-CD30-4A3C-A31F-F33FA10D3852 Q30827682-6D4FE5AF-2BE6-4F1B-BABE-2B2E0AE49397 Q33770734-260396E7-203C-4129-A5EE-0D4138F1ED5F Q33917545-4F5716FE-ED3D-4628-BD2A-CCA58BD939B6 Q34017405-49C65C57-A137-4DD1-BCBE-BF7D7BF2D01D Q34273397-BD57AE6C-DFE5-4FD5-834F-4601A33A2F78 Q34430020-4221E88A-B934-4AA5-9AB1-E669BEB218A2 Q34489464-E7A7834F-0142-4419-90BA-0A55ABBAD5B0 Q34593930-59DAE760-FBCB-4671-BB57-51AE3DCC2363 Q34706815-2E62C51D-5FDA-44AB-939C-6A0C7670CE5B Q34970515-A2EAA7A8-3B39-4E48-AC9C-6E6A6CE43D39 Q35666215-FAA10B64-F7F9-4F1D-8F30-210657A57A39 Q35925858-67B97F3C-3A41-490D-A904-136FD9704C6E Q36076282-B3A65BC5-3E29-4A44-94D4-3E6EEFBCDB62 Q36170089-AC98C83E-56EC-438A-8EA9-D2079423C546 Q36762590-AEAA5ED2-6348-412A-BE41-03FD08DBEE94 Q37123622-A700548D-02EF-40B5-9F96-AB513FE442A7 Q37247915-7AF6B60C-B47F-4E33-A39F-FEF6EFA5D1F2 Q37316019-75D03C49-2259-47AD-8AE0-1218D586F3DA Q37523428-8C411C03-4995-4EB3-9ACB-23A812833443 Q37641469-4E8D2257-AABE-426E-9EF8-DB4001883961 Q38232491-4802BA55-FBDF-4EA3-A9D3-7C1437BBC201 Q38870317-A4A16B12-466D-4BFB-B6C0-49CC82F47EED Q39044324-63056DF9-1ED6-4D36-A9FE-9A18EE609A83 Q39068831-E2E99B8C-5D9F-4CFD-A6DD-7E56B12A880A Q39139965-73DD8119-0770-4174-AFB9-E5B35B479CBA Q40046556-D9DCB8CD-9DF8-4B65-9352-5E3555A22888 Q40259573-0483F397-777C-4930-BE1B-8774B72BC0C5 Q42160644-C30D8B4C-9301-4441-8AAD-B4AC025A021F Q46781197-E4CED635-6A51-43F4-9FAA-0A3B19C2A73E Q47144668-D44BE20C-C979-4D00-9911-0B7E15758076

P2860

Assembly of human immunodeficiency virus (HIV) antigens on bacteriophage T4: a novel in vitro approach to construct multicomponent HIV vaccines.

http://www.wikidata.org/entity/Q35023762

description

2006 nî lūn-bûn

@nan

2006 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Assembly of human immunodefici ...... t multicomponent HIV vaccines.

@ast

Assembly of human immunodefici ...... t multicomponent HIV vaccines.

@en

type

label

Assembly of human immunodefici ...... t multicomponent HIV vaccines.

@ast

Assembly of human immunodefici ...... t multicomponent HIV vaccines.

@en

prefLabel

Assembly of human immunodefici ...... t multicomponent HIV vaccines.

@ast

Assembly of human immunodefici ...... t multicomponent HIV vaccines.

@en

P1433

Q35023762-1978C7E9-5D47-4F37-B0FB-7608817817EA

P1476

Q35023762-F1702630-6BB1-4069-93B1-6E22C1A861F8

P2093

Q35023762-15142BC8-ACAE-4741-9610-CD7CF2538109

Q35023762-96B8EB9F-A0E7-49C9-8E1A-57C719F905EC

Q35023762-D2ED7709-C24E-40AA-B5E6-0AC4F4DE8C0A

Q35023762-DF355C19-1881-4162-AC26-F6AFA3156522

Q35023762-ED974BE5-6A73-4BE7-8EAE-6FC8FB22D959

P2860

Q35023762-0DB1C6BC-9F51-4964-817F-7E5AECFFB455

Q35023762-1C061A3F-7CF0-405B-8403-5558412A5405

Q35023762-1DE6C053-5701-4CAD-8D9D-621C442F2A51

Q35023762-213C9854-D61D-479D-B854-5606932E5E29

Q35023762-21AC4829-97C2-4735-97D3-09322052C2C2

Q35023762-22738C7B-5758-490B-95D9-37112038DA3D

Q35023762-28FD55D0-280E-473B-93A6-61CE0553F3EF

Q35023762-31F0E0CD-AE82-4D34-A8D2-F090D25FB52D

Q35023762-35DC824D-1A7F-4169-9F5C-73D219C10136

Q35023762-3752708D-9CC1-4B1B-85AF-2A6742B986A4

P304

Q35023762-CFAA9244-B894-4A73-ABC5-06559BF9F016

P31

Q35023762-000FD26D-F2E2-4EB5-B361-C8EB8ADE6683

P356

Q35023762-C1C8B5AE-886F-4770-8EFC-2220BD107B6F

P407

Q35023762-E6968203-2B01-428F-AF69-0A74803B6B46

P433

Q35023762-1775556F-B3A7-4445-A8CC-521F645A49D9

P478

Q35023762-2636D39E-99BB-4C99-ACD7-8C3DDCD4FB5C

P50

Q35023762-88A874A2-4A76-4294-949F-BE01F78D2C36

P577

Q35023762-C485C540-8B3C-4112-97C8-708E6AC2B074

P5875

Q35023762-33DEA836-C755-4BE8-83E3-065CAA245740

P698

Q35023762-E64FC1C4-44CD-4CF2-9DF1-5C8CDB353E6D

P921

Q35023762-FDCED8D2-7F8E-499E-A6D8-F25A9B513455

P932

Q35023762-DECD46B5-5C2F-416D-AC2E-E7CD073EBA71

P356

P1433

Journal of Virology

P1476

Assembly of human immunodefici ...... t multicomponent HIV vaccines.

@en

P2093

Carl R Alving

http://www.w3.org/2001/XMLSchema#string

Danielle M Maclean

http://www.w3.org/2001/XMLSchema#string

Mangala Rao

http://www.w3.org/2001/XMLSchema#string

Taheri Sathaliyawala

http://www.w3.org/2001/XMLSchema#string

Venigalla B Rao

http://www.w3.org/2001/XMLSchema#string

P2860

The HIV-1 Envelope Glycoproteins: Fusogens, Antigens, and Immunogens

Use of T7 RNA polymerase to direct expression of cloned genes

Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface

The N-terminal ATPase site in the large terminase protein gp17 is critically required for DNA packaging in bacteriophage T4.

Bacteriophage lambda as a vehicle for peptide and protein display.

In vitro binding of anthrax protective antigen on bacteriophage T4 capsid surface through Hoc-capsid interactions: a strategy for efficient display of large full-length proteins.

The Nef protein of primate lentiviruses.

Contribution of virus-like particles to the immunogenicity of human immunodeficiency virus type 1 Gag-derived vaccines in mice

Induction of immune responses in mice and monkeys to Ebola virus after immunization with liposome-encapsulated irradiated Ebola virus: protection in mice requires CD4(+) T cells.

Viral persistence: HIV's strategies of immune system evasion.

P304

7688-7698

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.00235-06

http://www.w3.org/2001/XMLSchema#string

P407

P433

15

http://www.w3.org/2001/XMLSchema#string

P478

80

http://www.w3.org/2001/XMLSchema#string

P50

Deborah L. Birx

P577

2006-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6946071

http://www.w3.org/2001/XMLSchema#string

P698

16840347

http://www.w3.org/2001/XMLSchema#string

P921

P932

1563720

http://www.w3.org/2001/XMLSchema#string